Skip to main navigation Skip to search Skip to main content

Tyrosine kinase inhibitor levels matter in treating chronic GVHD

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Abstract

We observed a possible concentration effect relationship for nilotinib on resolution of chronic Graft versus Host disease.These data suggest therapeutic drug monitoring might be useful for patients receiving tyrosine kinase inhibitors for chronic GVHD.

Original languageEnglish
Pages (from-to)1141-1144
Number of pages4
JournalBone Marrow Transplantation
Volume54
Issue number7
Early online date16 Jan 2019
DOIs
Publication statusPublished - 1 Jul 2019

Fingerprint

Dive into the research topics of 'Tyrosine kinase inhibitor levels matter in treating chronic GVHD'. Together they form a unique fingerprint.

Cite this